AUR1545
AUR1545 is a selective degrader of KAT2A and KAT2B. AUR1545 can be used in the cancer research, including studies on AML (Acute myeloid leukemia), SCLC (Small-cell carcinoma), and NEPC (Neuroendocrine Prostate Cancer) [1].
Product Specifications
CAS Number
3031593-79-7
UNSPSC
12352005
Target
Histone Acetyltransferase
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.58
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C2=CC=C(N3CCN(CC3)CC4CCN(CC4)C(C5=CC=C([C@H]6C[C@H](CN(C6)C)NC7=C(C(N(N=C7)C)=O)Br)C=C5)=O)C=C2CN1C8C(NC(CC8)=O)=O
Molecular Formula
C41H50BrN9O5
Molecular Weight
828.80
References & Citations
[1]Kimberly S. Straley, et al. Abstract 5795: Potent and selective degradation of KAT2A and KAT2B induces profound cell state changes and inhibits growth of AML, SCLC and NEPC model systems. Cancer Res (2024) 84 (6_Supplement) : 5795.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
046866 50 µg
CAMK4/CaMKIV, Recombinant, Human, GST-Tag discontinued
Sign In for Pricing
View Details 
BNUM2001-50 1x 50 µL
IL-10R1, Mouse (Interleukin-10 Receptor 1) (CD210) (1B1.3a), 1mg/mL
Sign In for Pricing
View Details 
MBS1086583-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O9:H4 Putative aminoacrylate hydrolase RutD (rutD)
Sign In for Pricing
View Details MBS1086583-02 0.02 mg (Yeast)
Recombinant Escherichia coli O9:H4 Putative aminoacrylate hydrolase RutD (rutD)
Sign In for Pricing
View Details